Replies to post #599 on Aeolus Pharmaceuticals (AOLS)

[jimbob4stocks]

Couldn't agree more. Upside is too high to pass. Even if BARDA passes on Aeolus, which I don't believe will happen, this is a beautiful merger target. Zero debt with a rockstar compound. 10-K should release in mid- to late- December.